
No. of Pages: 158 | Report Code: BMIRE00028461 | Category: Life Sciences
No. of Pages: 158 | Report Code: BMIRE00028461 | Category: Life Sciences
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Blood Plasma Derivatives Market – by Type
1.3.2 Asia Pacific Blood Plasma Derivatives Market – by Application
1.3.3 Asia Pacific Blood Plasma Derivatives Market – by End User
1.3.4 Asia Pacific Blood Plasma Derivatives Market – by Country
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert’s Opinion
5.1 Market Drivers
5.1.1 Increase in Prevalence of Blood Disorders
5.1.2 Rise in Geriatric Population
5.2 Market Restraints
5.2.1 Complicated Reimbursement Policies
5.3 Market Opportunities
5.3.1 Incorporation of Platelet-Rich Plasma in Regenerative Medicine
5.4 Future Trends
5.4.1 Increasing Usage of Immunoglobulin G in Multiple Treatments
5.5 Impact Analysis
6.1 Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.1 Overview
7.2 Asia Pacific Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Albumin
7.3.1 Overview
7.3.2 Albumin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Factor VIII
7.4.1 Overview
7.4.2 Factor VIII: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Factor IX
7.5.1 Overview
7.5.2 Factor IX: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Immunoglobulin
7.6.1 Overview
7.6.2 Immunoglobulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 IgG
7.6.3.1 Overview
7.6.3.2 IgG: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.4 IgM
7.6.4.1 Overview
7.6.4.2 IgM: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.5 IgA
7.6.5.1 Overview
7.6.5.2 IgA: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.6 IgD
7.6.6.1 Overview
7.6.6.2 IgD: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.7 IgE
7.6.7.1 Overview
7.6.7.2 IgE: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Hyperimmune Globulin
7.7.1 Overview
7.7.2 Hyperimmune Globulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.1 Overview
8.2 Asia Pacific Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
8.3 Hemophilia
8.3.1 Overview
8.3.2 Hemophilia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hypogammaglobulinemia
8.4.1 Overview
8.4.2 Hypogammaglobulinemia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Von Willebrand Disease
8.6.1 Overview
8.6.2 Von Willebrand Disease: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Other Applications
8.7.1 Overview
8.7.2 Other Applications: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.1 Overview
9.2 Asia Pacific Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1 Overview
10.1.1 Asia Pacific: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)
10.1.1.1 Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Australia: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.1.3.1 Australia: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.1.4 Australia: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.1.5 Australia Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.2 China: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 China: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 China: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.2.3.1 China: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.2.4 China: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.2.5 China Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.3 India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.3.3.1 India: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.3.4 India: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.3.5 India Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.4 Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Japan: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.4.3.1 Japan: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.4.4 Japan: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.4.5 Japan Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.5 South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 South Korea: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.5.3.1 South Korea: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.5.4 South Korea: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.5.5 South Korea Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.6.3.1 Rest of Asia Pacific: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
11.1 Overview
11.2 Growth Strategies in the Blood Plasma Derivatives Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12.1 Grifols SA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 SK Plasma Co Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Octapharma AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Monobind Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Intas Pharmaceuticals Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Fusion Health Care Pvt Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Takeda Pharmaceutical Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 CSL Behring LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 LFB SA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Kedrion SpA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13.1 About The Insight Partners
13.2 Glossary of Terms
Table 1. Australia Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. Australia Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 3. Australia Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. Australia Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. China Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. China Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 7. China Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. China Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. India Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. India Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 11. India Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. India Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Japan Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Japan Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 15. Japan Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Japan Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. South Korea Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. South Korea Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 19. South Korea Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. South Korea Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Asia Pacific Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Asia Pacific Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Asia Pacific Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Asia Pacific Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Recent Inorganic Growth Strategies in the Blood Plasma Derivatives Market
Table 26. Recent Organic Growth Strategies in the Blood Plasma Derivatives Market
Table 27. Glossary of Terms
Figure 1. Asia Pacific Blood Plasma Derivatives Market Segmentation
Figure 2. Asia Pacific Blood Plasma Derivatives Market, by Country
Figure 3. Asia Pacific Blood Plasma Derivatives Market Overview
Figure 4. Immunoglobulin Segment Held Largest Share of Type Segment in Asia Pacific Blood Plasma Derivatives Market
Figure 5. India is Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Asia Pacific Blood Plasma Derivatives Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Asia Pacific Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
Figure 11. Albumin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Factor VIII: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Factor IX: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Immunoglobulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. IgG: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. IgM: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. IgA: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. IgD: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. IgE: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Hyperimmune Globulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Asia Pacific Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
Figure 23. Hemophilia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Hypogammaglobulinemia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Immunodeficiency Diseases: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Von Willebrand Disease: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other Applications: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Asia Pacific Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
Figure 29. Hospitals: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Clinics: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Other End Users: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Asia Pacific: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Growth Strategies in the Blood Plasma Derivatives Market